Functional Versus Anatomical Stenosis Evaluation Fractional Flow Reserve Defeats Intravascular Ultrasound⁎⁎Editorials published in JACC: Cardiovascular Interventions reflect the views of the authors and do not necessarily represent the views of JACC: Cardiovascular Interventions or the American College of Cardiology. by Rioufol, Gilles & Finet, Gérard
s
s
a
w
s
i
o
b
t
c
d
p
e
(
s
a
i
c
w
a
l
o
t
[
a
c
N
b
i
7
f
t
i
o
(
4
s
q
a
t
I
h
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 4 , N O . 7 , 2 0 1 1
© 2 0 1 1 B Y T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N I S S N 1 9 3 6 - 8 7 9 8 / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . D O I : 1 0 . 1 0 1 6 / j . j c i n . 2 0 1 1 . 0 6 . 0 0 3EDITORIAL COMMENT
Functional Versus Anatomical
Stenosis Evaluation
Fractional Flow Reserve Defeats
Intravascular Ultrasound*
Gilles Rioufol, MD, PHD, Gérard Finet, MD, PHD
Lyon, France
Beware so long as you live of judging men
by their outward appearance.
—Jean de la Fontaine (1)
Following Gould and Lipscomb’s seminal work in the
1970s, 50% coronary stenosis was shown to be liable to
reduce arterial blood flow in hyperemia: that is, in a
situation pragmatically equivalent to maximal effort (2). At
the time, functional flow analysis was not technologically
feasible, and coronarography became the reference tool for
diagnosis, prognosis, and stratification of coronary patients,
despite the limitations of angiography (3). Subsequently,
this 50% threshold became consecrated as indicating signif-
icant stenosis and possible revascularization strategy. Im-
proved visualization of coronary atheroma was later provided
by intravascular ultrasound (IVUS), enabling routine arterial
analysis at a resolution higher than with angiography (roughly
100 m vs. 250 m), free of plane confusion, and with arterial
wall visualization, which angiography cannot provide (4).
See page 803
In the late 1990s, device miniaturization allowed the
possibility of routine study of coronary hyperemia under
pharmacological stimulation, and fractional flow reserve
(FFR) proved its clinical interest in diagnosing functionally
significant stenosis (5), presently defined by consensus by an
FFR threshold of 0.80 under maximal hyperemia (6).
The temptation to correlate easily accessible IVUS data to
the functional information provided by FFR, not yet widely
available, led Takagi et al. (7) in 1999 to recommending a
3-mm2 IVUS minimum lumen area (MLA) cutoff as detecting
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pecificity. This 3-mm2 threshold has since been regularly
dopted as a surrogate for functionally significant stenosis.
Given that the anatomic distribution of the coronary net-
ork displays a fractal geometry, it seemed curious that there
hould be 1 magic number for MLA. Moreover, the functional
mplications of epicardial coronary stenosis depend, not simply
n the degree of stenosis in the epicardial conductance vessel,
ut also on stenosis length, myocardial microcirculation bed,
he myocardial mass perfused by the artery, and the degree of
ollateral circulation (8): functional assessment focusing on
egree of stenosis can only be reductive.
Since the 2000s, FFR-based functional strategies have
roved more effective than oculostenotic angiographic strat-
gies in single vessel (9) as in multivessel disease patients
6). The time had come to revise the relevance of anatomic
tenosis analysis as surrogate for functional impact.
In this issue of JACC: Cardiovascular Interventions, Koo et
l. (10) thus undertook a rigorous methodological compar-
son of FFR versus IVUS in 267 stenoses throughout the
oronary arteries. Patient selection for stable coronary lesion
ith underlying myocardium free of ischemic history en-
bled robust conclusions to be drawn.
Their main conclusion was that there is no threshold for
umen area reliably associated with FFR 0.80.
Lesions were pragmatically classed as proximal, medial,
r distal along the arteries and the correlations (except for
he proximal left anterior descending coronary artery
LAD]) were very poor. A proximal LAD lesion will
dmittedly show a better receiver-operator characteristic
urve in case of MLA3 mm2, the same value as in Takagi
et al. (7); however, 1 in 4 stenoses with MLA 3 mm2 will
nevertheless show FFR 0.80, which is a lot of uncertainty
as far as the individual patient is concerned.
A recent study by another Korean team (11), with a
comparable number of patients and an almost identical
design, came to the same conclusion: 2.4 mm2 MLA
stenosis rules out FFR 0.80 in 96% of cases, but 2.4
mm2 MLA is associated with 0.80 FFR in only 37%.
ondissociation between different arterial segments proba-
ly accounts for these findings.
The second major finding by Koo et al. (10) was the
mportance of the LAD. An intermediate lesion (30% to
0% angiographic stenosis) was 3.4 times as likely to be
unctionally significant if it was located on the LAD rather
han on any other artery, and this probability was further
ncreased (odds ratio [OR]: 2.97) if the lesion was, more-
ver, proximal. These findings were borne out by Kang et al.
11), who reported comparable ORs for the LAD (OR:
.4), although without difference according to proximal
tenosis location.
These findings may have practical routine conse-
uences. It would certainly henceforth be advisable, in
ase of positive stress test and only moderate proximal
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813LAD atheroma on angiography, to supplement invasive
exploration with FFR before concluding in favor of a
false-positive stress test: a false negative on the angio-
gram would be more likely.
Conversely, an angiographically tight lesion on the distal
LAD is unlikely to be associated with inducible ischemia,
and systematic revascularization needs reconsidering.
Finally, does IVUS still have any role to play in stable
angina? As far as diagnosis is concerned, that is a good
question; in the actual performance of complex angioplasty,
on the other hand, there remains no doubt that IVUS is of
great help and can optimize prognosis (12). Left main (LM)
lesions were not studied by Koo et al. (10), but this
particular anatomic situation deserves special attention: the
proximal location limits the variability of anatomic measure-
ment, and although FFR has been validated for diagnosis
and prognosis (13), MLA 5.9 mm2 on IVUS was vali-
dated against FFR (14) as indicating significant LM lesion
and guiding strategy. In LM evaluation, IVUS, unlike FFR,
provides useful information on plaque morphology and
extension to LAD and circumflex ostia, lengths, and refer-
ence diameters. Such anatomic data may guide a strategy of
interventional revascularization and optimize results (15),
whereas FFR provides no such anatomic information. A
role thus remains for IVUS in the diagnosis and interven-
tional treatment of LCA stenosis in centers where the policy
is PCI; when, however, PCI is not intended, FFR is
pragmatically the method of choice.
In conclusion, in light of the findings by Koo et al. (10)
and other teams, the debate between morphological and
functional approaches is going ever more in favor of func-
tion, and so of FFR, in evaluating coronary stenosis. If
IVUS has lost its place in the evaluation of stable ischemia
despite its good resolution, then logically, the same should
go for angiography and for cross-sectional imaging such as
computed tomography scan and optical coherence tomog-
raphy. In Europe, FFR currently enjoys class IA recommen-
dation for assessment of stable coronary stenosis ahead of
revascularization (16) when functional information is lack-
ing; the question of generalizing FFR as a first-line cath lab
tool is henceforth on the table.
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